PaulD.RyanMD

PubMed

• Overexpression of BLM Promotes DNA Damage and Increased Sensitivity to Platinum Salts in Triple Negative Breast and Serous Ovarian Cancers
  D P Silver, J E Garber, N Tung, Z C Wang, A L Richardson, Y Li, P D Ryan> ;Annals of Oncology. 2018 Feb 17
• Which individuals undergoing BRACAnalysis need BART testing?
  Shannon, K. M., Rodgers, L. H., Chan-Smutko, G., Patel, D., Gabree, M., Ryan, P. D.> ;Cancer Genet. 2011 Aug
• Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers.
  Schrader, K. A., Masciari, S., Boyd, N., Salamanca, C., Senz, J., Saunders, D. N., Yorida, E., Maines-Bandiera, S., Kaurah, P., Tung, N., Robson, M. E., Ryan, P. D., O...> ;J Med Genet. 2011 Jan
• Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers.
  Tung, N., Miron, A., Schnitt, S. J., Gautam, S., Fetten, K., Kaplan, J., Yassin, Y., Buraimoh, A., Kim, J. Y., Szász, A. M., Tian, R., Wang, Z. C., Collins, L. C., Bro...> ;Breast Cancer Res. 2010
• Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.
  Lee, J. M., McMahon, P. M., Kong, C. Y., Kopans, D. B., Ryan, P. D., Ozanne, E. M., Halpern, E. F., Gazelle, G. S.> ;Radiology. 2010 Mar
• Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.
  Silver, D. P., Richardson, A. L., Eklund, A. C., Wang, Z. C., Szallasi, Z., Li, Q., Juul, N., Leong, C. O., Calogrias, D., Buraimoh, A., Fatima, A., Gelman, R. S., Rya...> ;J Clin Oncol. 2010 Mar 1
• Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features.
  Tung, N., Wang, Y., Collins, L. C., Kaplan, J., Li, H., Gelman, R., Comander, A. H., Gallagher, B., Fetten, K., Krag, K., Stoeckert, K. A., Legare, R. D., Sgroi, D., R...> ;Breast Cancer Res. 2010
• VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy.
  Burstein, H. J., Chen, Y. H., Parker, L. M., Savoie, J., Younger, J., Kuter, I., Ryan, P. D., Garber, J. E., Chen, H., Campos, S. M., Shulman, L. N., Harris, L. N., Ge...> ;Clin Cancer Res. 2008 Dec 01
• Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort.
  Wittner, B. S., Sgroi, D. C., Ryan, P. D., Bruinsma, T. J., Glas, A. M., Male, A., Dahiya, S., Habin, K., Bernards, R., Haber, D. A., Van't Veer, L. J., Ramaswamy, S.> ;Clin Cancer Res. 2008 May 15
• Professional challenges in cancer genetic testing: who is the patient?
  Chan-Smutko, G., Patel, D., Shannon, K. M., Ryan, P. D.> ;Oncologist. 2008 Mar
• Breast cancer screening in BRCA1 mutation carriers: effectiveness of MR imaging--Markov Monte Carlo decision analysis.
  Lee, J. M., Kopans, D. B., McMahon, P. M., Halpern, E. F., Ryan, P. D., Weinstein, M. C., Gazelle, G. S.> ;Radiology. 2008 Mar
• The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer.
  Ryan, P. D., Goss, P. E.> ;Oncologist. 2008 Jan
• Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer.
  Harris, L. N., You, F., Schnitt, S. J., Witkiewicz, A., Lu, X., Sgroi, D., Ryan, P. D., Come, S. E., Burstein, H. J., Lesnikoski, B. A., Kamma, M., Friedman, P. N., Ge...> ;Clin Cancer Res. 2007 Feb 15
• Uptake of BRCA1 rearrangement panel testing: in individuals previously tested for BRCA1/2 mutations.
  Shannon, K. M., Muzikansky, A., Chan-Smutko, G., Niendorf, K. B., Ryan, P. D.> ;Genet Med. 2006 Dec
• Adjuvant hormonal therapy in peri- and postmenopausal breast cancer.
  Ryan, P. D., Goss, P. E.> ;Oncologist. 2006 Jul 01
• Case records of the Massachusetts General Hospital. Case 6-2006. A 71-year-old woman with urinary incontinence and a mass in the bladder.
  Ryan, P. D., Harisinghani, M., Lerwill, M. F., Kaufman, D. S.> ;N Engl J Med. 2006 Feb 23
• The evolving role of aromatase inhibitors in the treatment of early-stage breast cancer.
  Ryan, P. D., Goss, P. E.> ;Nat Clin Pract Oncol. 2005 Dec
• Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy.
  Burstein, H. J., Parker, L. M., Keshaviah, A., Doherty, J., Partridge, A. H., Schapira, L., Ryan, P. D., Younger, J., Harris, L. N., Moy, B., Come, S. E., Schumer, S. ...> ;J Clin Oncol. 2005 Nov 20
• Case records of the Massachusetts General Hospital. Case 24-2005. A 58-year-old woman with early-stage estrogen-receptor-positive breast cancer.
  Ryan, P. D., Kopans, D. B., Sgroi, D. C.> ;N Engl J Med. 2005 Aug 11
• RE: A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen.
  Sgroi, D. C., Haber, D. A., Ryan, P. D., Ma, X. J., Erlander, M. G.> ;Cancer Cell. 2004 Nov
• A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen.
  Ma, X. J., Wang, Z., Ryan, P. D., Isakoff, S. J., Barmettler, A., Fuller, A., Muir, B., Mohapatra, G., Salunga, R., Tuggle, J. T., Tran, Y., Tran, D., Tassin, A., Amon...> ;Cancer Cell. 2004 Jun
• Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 28-2003. A 51-year-old premenopausal woman with newly diagnosed breast c...
  Ryan, P. D., Haber, D. A., Shannon, K. M., Smith, B. L., Fan, M. J.> ;N Engl J Med. 2003 Sep 11
• Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of seru...
  Burstein, H. J., Harris, L. N., Marcom, P. K., Lambert-Falls, R., Havlin, K., Overmoyer, B., Friedlander, R. J., Gargiulo, J., Strenger, R., Vogel, C. L., Ryan, P. D.,...> ;J Clin Oncol. 2003 Aug 1
• Women's interest in chemoprevention for breast cancer.
  Bastian, L. A., Lipkus, I. M., Kuchibhatla, M. N., Weng, H. H., Halabi, S., Ryan, P. D., Skinner, C. S., Rimer, B. K.> ;Arch Intern Med. 2001 Jul 9
• On receptor inhibitors and chemotherapy.
  Ryan, P. D., Chabner, B. A.> ;Clin Cancer Res. 2000 Dec
• Join now to see all